Navigation Links
Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
Date:11/6/2007

/p>

indicated that a future New Drug Application filing for this product

candidate could be eligible to receive priority review. The company

plans to initiate a Phase II clinical trial in the fourth quarter of

2007.

-- Interim data have been obtained from two single dose studies, one in

healthy volunteers and one in epilepsy patients, of JZP-4, a product

candidate for the treatment of partial epilepsy and bipolar disorder.

The data from both of these studies indicate biological activity in

human epilepsy models. A single dose study of a controlled-release

formulation of JZP-4 is underway, and is expected to complete in the

fourth quarter of 2007. Jazz Pharmaceuticals plans to initiate

Phase II clinical trial activities for JZP-4 by the end of 2007.

-- A second pharmacokinetic study of JZP-7, a product candidate for the

treatment of restless legs syndrome, was initiated in the third quarter

of 2007, and Jazz Pharmaceuticals expects top line results from that

study in the second quarter of 2008.

-- In August 2007, the U.S. Patent and Trademark Office (USPTO) awarded

Jazz Pharmaceuticals a new U.S. patent (No. 7,262,219) titled

"Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate

Salt for the Treatment of Narcolepsy." This Xyrem patent is now listed

in the FDA's Orange Book.

Jazz Pharmaceuticals will host an investor conference call and live audio webcast to discuss its quarterly results on November 6, 2007 at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time. The live webcast and press release may be accessed on Jazz Pharmaceuticals' website at http://www.JazzPharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that m
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
10. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
11. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 20, 2014 The newly updated Worldwide ... of thousands of facts, figures and forecasts on the ... medical sector forecast categories the Worldwide Medical Market ... and national views on the worldwide medical market to ... report gives you data for 2010-2019, covering each country ...
(Date:10/20/2014)... 2014 Allegheny General Hospital’s (AGH) Cardiovascular ... physicians to repair a damaged mitral valve as the ... system, developed by Abbott Vascular , is designed ... life-threatening condition in which the heart’s mitral valve leaflets ... from the heart’s left ventricle into the left atrium. ...
(Date:10/20/2014)... 20, 2014 ASCNYC (ascnyc.org) is ... helps New Yorkers living with HIV/AIDS and other ... housing, recovery and self-sufficiency. Each year, ASCNYC spotlights ... community through their tireless efforts. , Savills ... , has been selected as this year’s honoree ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 T.E.N., ... relationship-marketing firm, announced today that William H. Murray, ... the 2014 ISE® Luminary Leadership Award winner. Presented ... achievements of an outstanding leader and industry practitioner ... contributions in advancing the information security industry. , ...
(Date:10/20/2014)... Zereana Jess-Huff, a 34-year-old mother, corporate executive and ovarian ... to think outside the bra. She doesn’t try to hide ... awareness about women’s other lady parts. , "We have won ... color pink and everybody knows what you’re talking about,” Jess-Huff ... has not been won when it comes to gynecologic cancers. ...
Breaking Medicine News(10 mins):Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 2Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 3Health News:Bill Murray named 2014 ISE® Luminary Leadership Award Winner 4Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
... Mich. The largest and most up-to-date study of ... may help guide screening and treatment for all veterans. ... finds that the predictors of suicide among veterans in ... American population, with younger, white, non-Hispanic men having the ...
... 30 BioMed Realty Trust, Inc.,(NYSE: BMR ) ... quarter,ended September 30, 2007 after the market closes on ... Chief Executive Officer, and Kent Griffin,Chief Financial Officer, will ... on Thursday, November 8, 2007 to discuss the company,s,financial ...
... Oct. 30 The U.S. Department,of Health and ... announced two new tools to help pharmacies provide ... The tools are titled, Is,Our Pharmacy Meeting Patients, ... and Strategies to Improve Communication between Pharmacy,Staff and ...
... November 4,2007, Eli Lilly and Company (NYSE: LLY ... and media to review the details of prasugrel,scientific data ... Orlando, Florida. This call will follow the TIMI,Study Group,s ... The Lilly conference call will be held from ...
... Promise as Metastatic Cancer Treatment , The Seneca ... differentiate between normal and cancerous cells. The virus may ... as small-cell lung cancer. , Cancer-killing viruses have been ... localized cancer. But so far their success has been ...
... Marathon 2007 and be Recognized for ... and Avis, NEW YORK, Oct. 30 New York ... that Vincent Corso and Daniel Trush have,won the fourth-annual Avis ... City Marathon 2007. The award celebrates people who endeavor,to overcome ...
Cached Medicine News:Health News:Key findings for all veterans seen in depression and suicide study 2Health News:Key findings for all veterans seen in depression and suicide study 3Health News:Key findings for all veterans seen in depression and suicide study 4Health News:BioMed Realty Trust to Report 2007 Third Quarter Results 2Health News:New AHRQ Tools Help Pharmacies Better Serve Patients With Limited Health Literacy 2Health News:Other highlights in the Oct. 30 JNCI 2Health News:Other highlights in the Oct. 30 JNCI 3Health News:Other highlights in the Oct. 30 JNCI 4Health News:Vincent Corso and Daniel Trush Win 2007 Avis 'We Try Harder' Awards 2Health News:Vincent Corso and Daniel Trush Win 2007 Avis 'We Try Harder' Awards 3
(Date:10/22/2014)... ANAHEIM, Calif. , Oct. 21, 2014 Influenza ... with flu-associated deaths in the United States ... influenza viruses are thought to spread is from person to ... Ebola has a serve way of death, but kills ... of Ebola is also done by human fluids including sweat, ...
(Date:10/22/2014)... YORK , Oct. 22, 2014 Sanomedics ... August 2014 report by Global Research & Data Services, ... per year from 2014 through 2018, as demand for ... States is the world,s largest market for ... with advanced thermometers is Sanomedics International Holdings, Inc. ...
(Date:10/22/2014)... Oct. 22, 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: ... its novel investigational drug for cancer, is designed for ... side effects. Its oncology focus is on melanoma, breast ... phase 2 trials of PV-10 as a therapy for ... for atopic dermatitis and psoriasis. This ...
Breaking Medicine Technology:WholeHealth Products is proud to be releasing its Influenza A and B combo test, on the heels of the announcing of its phase 2 completion of the Rapid Ebola Test 2Sanomedics International Holdings Analyst Report: Taking Some Heat by BrokerBank Securities, Inc. 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
... Reportlinker.com announces that a new market research report ... Sepsis http://www.reportlinker.com/p0484945/Epidemiology-Sepsis.html ... seven major markets, especially in intensive care units. Datamonitor ... incident cases of severe sepsis in the seven major ...
... LAKE FOREST, Ill., April 26, 2011 Hospira, Inc. ... pharmaceutical and medication delivery company, today reported results for ... for the quarter were $1.0 billion, and adjusted* diluted ... specified items as described later in this press release ...
Cached Medicine Technology:Reportlinker Adds Epidemiology: Sepsis 2Hospira Reports First-Quarter 2011 Results 2Hospira Reports First-Quarter 2011 Results 3Hospira Reports First-Quarter 2011 Results 4Hospira Reports First-Quarter 2011 Results 5Hospira Reports First-Quarter 2011 Results 6Hospira Reports First-Quarter 2011 Results 7Hospira Reports First-Quarter 2011 Results 8Hospira Reports First-Quarter 2011 Results 9Hospira Reports First-Quarter 2011 Results 10Hospira Reports First-Quarter 2011 Results 11Hospira Reports First-Quarter 2011 Results 12Hospira Reports First-Quarter 2011 Results 13
... Stellate Harmonie workstation is a medical device ... high quality video capability, and archiving demands ... review functions A framework that helps organize ... of data A centralized database and powerful ...
...
These are superior quality electrodes, fabricated from a single length of polyurethane tubing for strength and uniform smoothness. They are furnished with a specially-designed rigid stylet to facilit...
Integra Epilepsy grid electrodes are thin and flexible for easier placement and to conform to the curvature of the cortical surface. Lead tunneling is done using a 14-gauge tunneling needle (ET-2)....
Medicine Products: